Merck to reveal new major installment to support health research with a translational component in Quebec

These multi-million dollar grants will be used to enhance the academic research environment at four Quebec Universities

QUEBEC CITY, Oct. 2, 2013 /CNW Telbec/ - Members of the media are invited to a press conference during which new multi-million dollar grants to support health research with a translational component will be announced as the next installment of the $100-million commitment of Merck to fund research innovation in Quebec.

The announcement will be made during the BioContact Quebec 2013 biopharmaceutical partnership symposium, on October 3rd, 2013.


What:  Press conference of Merck Canada at BioContact Quebec 2013
Who: Mr. Pierre Duchesne, Minister of Higher Education, Research,
Science and Technology
Dr. Thomas R. Cannell, President and Managing Director,
Merck Canada Inc.
Mr. Denis Brière, President, Université Laval
Pr. Daniel Bourbonnais, Associate Dean-Research and
Scientific Innovation, Université de Montréal
Pr. Jean-Pierre Perreault, PhD, Vice-Dean of Research
and Graduate Studies, Faculté de médecine et des sciences de la santé,
Université de Sherbrooke
Philippe Gros, PhD, Vice-Dean, Life Sciences, Faculty of Medicine, McGill University
When:   Thursday, October 3rd, 2013 at 1:30 p.m.
  1:30 p.m. Press conference begins
  1:55 p.m. One-on-one interviews and photo opportunity
Hotel Chateau Laurier Quebec - Espace Foyer des Plaines
1220, Place George-V West
Quebec City, Quebec G1R 5B8




For further information:

Sylvie Patry
Office : 418-648-1233 ex: 232
Mobile : 418-454-1088

Stephanie Lyttle
Office: 514-843-2365
Mobile: 514-501-8685

Roch Landriault
Office: 514-843-2345
Mobile: 514-249-4537

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890